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Phospholipase A2s generate lipid mediators that constitute an important component of the integrated 
response of macrophages to stimuli of the innate immune response. Because these cells contain multiple 
phospholipase A2 forms, the challenge is to elucidate the roles that each of these forms plays in regulating 
normal cellular processes and in disease pathogenesis. A major issue is to precisely determine the 
phospholipid substrates that these enzymes use for generating lipid mediators. There is compelling 
evidence that group IVA cytosolic phospholipase A2 (cPLA2α) targets arachidonic acid–containing 
phospholipids but the role of the other cytosolic enzyme present in macrophages, the Ca2+-independent 
group VIA phospholipase A2 (iPLA2β) has not been clearly defined. We applied mass spectrometry–based 
lipid profiling to study the substrate specificities of these two enzymes during inflammatory activation of 
macrophages with yeast-derived zymosan, a phagocytosable particle. Using selective inhibitors, we find 
that, contrary to cPLA2α, iPLA2β spares arachidonate-containing phospholipids and hydrolyzes only 
those that do not contain arachidonate, in particular choline phospholipids containing palmitic acid at the 
sn-1 position. This in turn results in the liberation of palmitoleic acid, which is incorporated into inositol 
lipids. The biological significance of this novel iPLA2β-driven pathway will be discussed.  
Transcription of the lecture presented on Thursday, May 18, 2016 at the 7th International Conference on 
Phospholipase A2 and Lipid Mediators, La Jolla, California, U.S.A. (Slide 1).  
As many of you know, I was a postdoc with Ed in the 90’s and spent many years here in la Jolla, so I thought it 
would be good to start my talk by showing the very first picture I have with Ed. This is the Fall of 93, that is 23 
years ago. Obviously, I look much younger, but if you look at Ed, you’ll notice that he looks today very much as 
he looked 23 years ago… (Slide 2). Well, scientifically-wise, if I had to summarize my years at UCSD with just 
one image, this would be it (Slide 3 – Distinct Roles in Signal Transduction). This is the scheme we worked on 
for all those years to define the roles of multiple phospholipase A2s in arachidonic acid mobilization in 
macrophages; cPLA2 as the key enzyme, sPLA2 in an amplifying role, and iPLA2 helping replenish the AA 
pools by regulating lyso availability. I know Ed does not use it anymore and I don’t either, but we published it 
in a number of papers over the years, and we even got it on the cover of JBC (Slide 4). Most of these studies 
with Ed focused to PLA2-mediated AA mobilization in macrophages, so today I’m going to talk about 
phospholipids that do not have AA, what happens to them during macrophage activation (Slide 5 – What About 
Phospholipids Without Arachidonate?). To study this we used the following protocol (Slide 6 – Lipidomic 
Profiling of Phospholipids Without  AA). This figure shows a mass spec analysis of major phosphatidylcholine 
(PC) species after zymosan activation, and the effect of the PLA2 inhibitors FKGK18 (iPLA2β) and 
pyrrophenone (cPLA2α) (Slide 7 – Major PC Species Without  AA  in Zymosan-stimulated Macrophages). We 
found quite significant decreases in some of these phospholipids, indicating that not only AA is released during 
activation but other fatty acids follow the same fate. Interestingly, FKGK18 but not pyrrophenone was able to 
prevent these decreases, suggesting a role for iPLA2β. The most prominent effects were found in the two major 
species measured –PC(32:0) and PC(34:1)–, the levels of which were completely restored in the presence of 
FKGK18. These two species could be identified as PC(16:0/16:0) and PC(16:0/18:1) in fragmentation 
experiments. Minor species whose hydrolysis was completely prevented by FKGK18 were PC(32:1) and 
PC(34:2), and these also could be identified by fragmentation experiments as PC(16:0/16:1) and PC(16:0/18:2). 
Therefore, it is striking that four phospholipids identified as iPLA2β substrates during zymosan activation all 
contain palmitic acid (16:0) esterified at the sn-1 position. Actually when we measured lysolipid production in 
activated macrophages, palmitoyl-lysoPC was the major species produced and this production was strongly 
blocked by FKGK18, again suggesting that iPLA2β may be a major contributor to this accumulation (Slide 8 – 
Lysophospholipid Production in Zymosan-stimulated Macrophages).  Note in contrast the other major lysolipid 
produced in the activated macrophages, stearoyl-lysoPC, whose levels are affected little by FKGK18 but 
strongly by pyrrophenone, suggesting a link of this species to cPLA2α. So in the end, as a conclusion of these 
experiments, in activated cells, iPLA2β displays some sort of specificity for PC molecules containing palmitic at 
the sn-1 position (Slide 9 –  iPLA2 May Have Preference for sn-1 palmitoyl PC). 
When we examined the inositol lipids we found a few of them that showed an unexpected behavior, as they 
increased instead of going down. However the increase was partially prevented by FKGK18 but not by 
pyrrophenone, suggesting that iPLA2β may be involved (Slide 10 – Minor PI Species Without  AA in Zymosan-
stimulated Macrophages). These species have in common that all possess a 16:1 fatty acid residue. And it is 
interesting to note that two of them, the two that increase the most, were not found in resting cells, suggesting 
that if the cells make them, they must have some biological function. So the question is, where does 16:1-PI 
come from? (Slide 11 – Where Does 16:1-PI Come from?).  We measured all the phospholipids that have 16:1 
and this is what we found (Slide 12 – 16:1-containing Phospholipids in Resting Macrophages).  Most of the 
fatty acid is in PC, especially in one species, PC(16:0/16:1), while all other classes contained lesser amounts. 
Now we remind you that this PC species is one of those that I shown in the previous slide that was hydrolyzed 
by iPLA during activation to give rise to palmitoyl-lysoPC. So we measured the levels of the 16:1-containing 
phospholipids and found that PC(16:0/16:1) was the only that decreased and the ones that increased were the 
two preexisting PI molecules plus the 2 newly-formed (Slide 13 – 16:1-containing Phospholipids in Stimulated 
Macrophages). So, it is likely that much of the 16:1 fatty acid accumulating in PI comes from PC in a reaction 
that is sensitive to FKGK18 and thus probably mediated by iPLA2β (Slide 14 – Where Does 16:1-PI Come 
from? -PC(16:0/16:1). One problem with this explanation is that the amount lost from PC is generally less than 
the amount gained by the PIs. Thus there is possibly a second source for 16:1 for PI. We measured the 
distribution of 16:1 among lipid classes, phospholipids and neutral lipids by GC/MS, and were surprised to find 
that depending on the lipid class measured, there were two peaks of 16:1 (phospholipids) or only one (neutral 
lipids) (Slide 15 – Two 16:1 Isomers in Macrophages). Comparison with commercial standards indicated that 
one was 16:1n-7 or palmitoleic acid proper and the other could either be 16:1n-10 (sapienic acid) or 16:1n-9 
(Slide 16 – Two 16:1 Isomers in Macrophages). We made the DMOX derivative and analyzed it by electron 
impact MS. Confirming it was actually 16:1n-9, a relatively unusual fatty acid (Slide 17 – The Second Isomer is 
16:1n-9). As commented before, there is a fundamental difference in the distribution of these two isomers 
among lipid classes, the n-9 isomer localizes in both phospholipid and neutral lipids, whereas n-7 only appears 
in phospholipid (Slide 18 – Distribution of 16:1 Isomers Between Lipid Classes). This distribution of n-9 is 
quite peculiar since no other fatty acid distributes similarly (Slide 19 – Distribution of 16:1 Isomers Between 
Lipid Classes). When we analyzed the distribution of n-9 in zymosan-treated cells, we found that it increases in 
all lipid classes but the highest increases are in neutral lipids (Slide 20 – Distribution of 16:1 Isomers Between 
Lipid Classes).   
The unique distribution of 16:1n-9 among cellular lipids and the finding that its levels are increased during 
cellular activation suggest a specific biological role for this unusual fatty acid. To study this question, we 
prepared cells enriched in this fatty acid by incubating them with 10 µM 16:1n-9 for 2 h in serum-free medium. 
This procedure results in the cells taking up the fatty acid and preferentially accumulating it in neutral lipids, in 
a similar manner as if they had been previously activated with a receptor-directed stimulus. Then, the cells were 
stimulated with LPS and the effects on the expression of a number of proinflammatory genes was investigated 
(Slide 21 – 16:1n-9 Possesses Anti-inflammatory Properties in vitro). Cells enriched in 16:1n-9 showed 
significant decreases in the expression of all genes tested, and such decreases were generally comparable to 
those found in the 22:6n-3-treated cells. 16:1. 16:1n-9 was significantly more potent than 16:1n-7 for all genes 
tested; 16:1n-7 had significant effects only in two of them, Tnf and Nos2. These data show  that 16:1n-9 has a 
spectrum of biological activity that is clearly distinguishable from that of 16:1n-7. We also conducted 
experiments with mice (Slide 22 – 16:1n-9 Possesses Anti-inflammatory Properties in vivo). In these 
experiments, the fatty acid was administered i.p. to mice 1 h before i.p. injection of LPS for 6 h. Afterward, the 
animals were sacrificed, peritoneal cells were harvested, cell samples matched by protein content, and the 
expression levels of Il6 were studied. Both 16:1n-9 and 22:6n-3 inhibited Il6 gene expression by the peritoneal 
cells isolated after the LPS challenge. Analysis of serum IL-6 protein confirmed a strong decrease in the amount 
of circulating IL-6 protein in the 16:1n-9-treated mice. Unexpectedly, IL-6 protein levels in serum from 22:6n-3 
treated cells were no different from those in serum from control untreated animals. 
So, in conclusion, these results suggest that the relatively uncommon fatty acid acid 16:1n-9 may possess anti-
inflammatory activity that could be comparable to that of omega-3 fatty acids, and clearly distinguishable from 
that of palmitoleic acid. From a biochemical point of view this fatty acid shows unique characteristics, such as 
its accumulation in PI molecules (perhaps via an iPLA2β-mediated pathway) and also in neutral lipids. Well I 
started with mu very first pic with Ed during may stay at UCSD and would like to end with the last picture I 
have with him from these wonderful years (Slide 24 – The Dennis Group 2000). This is the summer of 2000 I 
believe, a few weeks before I left the lab. You can see that Ed, of course, looks the same as he looks today. Just 
to conclude, the Acknowledgments slide (Slide 25 – Acknowledgments). 
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